Literature DB >> 21921951

Diagnostic efficacy of total homocysteine and C-reactive protein for ocular ischemic syndrome.

I H Hong1, J K Ahn, S Chang, S P Park.   

Abstract

BACKGROUND: To assess diagnostic efficacy of plasma total homocysteine (tHcy) and C-reactive protein (CRP) levels for ocular ischemic syndrome (OIS).
METHODS: In all, 87 patients with retinal vein occlusion (RVO), 955 patients with a stenosis of internal carotid artery (ICA) <90% and 159 patients with a stenosis of ICA >90% were included between 2003 and 2009. A total of 43 patients with a stenosis ICA >90% were diagnosed as OIS. Fasting tHcy, CRP, lipid profiles, creatinine were measured, and diagnostic values of hyperhomocysteinemia or elevated CRP for OIS were evaluated. RESULT: The mean plasma levels of tHcy (18.8 μmol/l) and CRP (1.1 mmol/l) were the highest in patients with OIS among the groups. The prevalences of hyperhomocysteinemia (72%) and elevated CRP (77%) were the highest in OIS among the groups. In patients with stenosis of ICA, the diagnostic sensitivity/specificity for OIS was 70/79% in hyperhomocysteinemia and 73/73% in elevated CRP. The diagnostic sensitivity and specificity for OIS were 53 and 86% in both hyperhomocysteinemia and elevated CRP. The lipid profiles and creatinine levels were similar among the groups.
CONCLUSION: Our results suggest that hyperhomocysteinemia and elevated CRP may be associated with the development of OIS. The measurements of tHcy and CRP in blood may help to assist the diagnosis of OIS in a stenosis of ICA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921951      PMCID: PMC3234474          DOI: 10.1038/eye.2011.232

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  16 in total

Review 1.  An update on the role of markers of inflammation in atherosclerosis.

Authors:  Egle Corrado; Manfredi Rizzo; Giuseppe Coppola; Khalil Fattouch; Giuseppina Novo; Ilenia Marturana; Filippo Ferrara; Salvatore Novo
Journal:  J Atheroscler Thromb       Date:  2009-12-24       Impact factor: 4.928

2.  Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease.

Authors:  David Tanne; Moti Haim; Uri Goldbourt; Valentina Boyko; Ram Doolman; Yehuda Adler; Daniel Brunner; Solomon Behar; Ben-Ami Sela
Journal:  Stroke       Date:  2003-02-20       Impact factor: 7.914

3.  Direct proinflammatory effect of C-reactive protein on human endothelial cells.

Authors:  V Pasceri; J T Willerson; E T Yeh
Journal:  Circulation       Date:  2000-10-31       Impact factor: 29.690

4.  Ocular ischemic syndrome.

Authors:  J B Mizener; P Podhajsky; S S Hayreh
Journal:  Ophthalmology       Date:  1997-05       Impact factor: 12.079

5.  The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment.

Authors:  A Sivalingam; G C Brown; L E Magargal
Journal:  Int Ophthalmol       Date:  1991-01       Impact factor: 2.031

6.  Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis.

Authors:  J H Yoo; C S Chung; S S Kang
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

7.  Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.

Authors:  Lorenzo Di Crecchio; Maurizio Battaglia Parodi; Giorgia Sanguinetti; Pierluigi Iacono; Giuseppe Ravalico
Journal:  Ophthalmology       Date:  2004-05       Impact factor: 12.079

Review 8.  Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.

Authors:  Daniel G Hackam; Sonia S Anand
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

9.  Ischemic oculopathy. A manifestation of carotid artery disease.

Authors:  L H Young; R E Appen
Journal:  Arch Neurol       Date:  1981-06

10.  Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease.

Authors:  Mark T Cahill; Sandra S Stinnett; Sharon Fekrat
Journal:  Am J Ophthalmol       Date:  2003-12       Impact factor: 5.258

View more
  1 in total

1.  Clinical Analysis of 42 Cases of Ocular Ischemic Syndrome.

Authors:  Jingyi Luo; Zhichao Yan; Yu Jia; Rongjiang Luo
Journal:  J Ophthalmol       Date:  2018-03-11       Impact factor: 1.909

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.